Similarly, another study reported that PPARβ/δ is not a potential biomarker for assessing the degree of malignancy or a prognosis predictor of PCa because there was no correlation found between the expression of PPARβ/δ and patient survival (Forootan et al., 2014) (Table 2). Here, PPARD is linked to posterior cortical atrophy.